Batchelor Ann-Louise has filed 18 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 142000 shares of VOLITIONRX LTD ($VNRX) on February 26, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | A | Common Stock | 142000 | $0.00 | 353,478.0000 | 122,801,572 | 67.15% | 0.12% |
| Jan. 22, 2026 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | A | Common Stock | 33900 | $0.00 | 211,478.0000 | 122,801,572 | 19.09% | 0.03% |
| Oct. 4, 2025 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | F | Common Stock | 6110 | $0.65 | 177,578.0000 | 96,543,744 | 3.33% | 0.01% |
| Sept. 28, 2025 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | F | Common Stock | 5604 | $0.61 | 183,688.0000 | 96,543,744 | 2.96% | 0.01% |
| Aug. 15, 2025 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | A | Common Stock | 27400 | $0.00 | 189,292.0000 | 96,543,744 | 16.92% | 0.03% |
| Aug. 1, 2025 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | F | Common Stock | 8620 | $0.64 | 161,892.0000 | 96,543,744 | 5.06% | 0.01% |
| July 1, 2025 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | F | Common Stock | 6177 | $0.77 | 170,512.0000 | 96,543,744 | 3.50% | 0.01% |
| June 1, 2025 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | A | Common Stock | 18341 | $0.00 | 176,689.0000 | 96,543,744 | 11.58% | 0.02% |
| March 1, 2025 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | A | Common Stock | 14233 | $0.00 | 158,348.0000 | 0 | 9.88% | 0.00% |
| Jan. 29, 2025 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 29, 2025 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 1, 2024 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | A | Common Stock | 13143 | $0.00 | 144,115.0000 | 0 | 10.03% | 0.00% |
| Oct. 4, 2024 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | F | Common Stock | 6110 | $0.88 | 130,972.0000 | 0 | 4.46% | 0.00% |
| Sept. 28, 2024 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | F | Common Stock | 5604 | $0.58 | 137,082.0000 | 0 | 3.93% | 0.00% |
| Sept. 1, 2024 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | A | Common Stock | 13731 | $0.00 | 142,686.0000 | 0 | 10.65% | 0.00% |
| Aug. 15, 2024 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | A | Common Stock | 13250 | $0.00 | 128,955.0000 | 0 | 11.45% | 0.00% |
| June 1, 2024 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | A | Common Stock | 11685 | $0.00 | 115,705.0000 | 0 | 11.23% | 0.00% |
| Jan. 24, 2024 | VOLITIONRX LTD | $VNRX | Batchelor Ann-Louise | Group Chief Marketing Officer | A | Common Stock | 22525 | $0.00 | 104,020.0000 | 0 | 27.64% | 0.00% |